Four therapeutic areas

Solvay Pharmaceuticals’ research and development is focused on four therapeutic areas: 

• cardio-metabolic: Arrhythmia, Cardio-metabolic disorders, Congestive heart failure, Hypertension, Obesity.
• neuroscience: Anxiety and depression, Psychosis, Parkinson’s disease and neurology.
• influenza vaccines: new delivery systems, adjuvants.
• pancreatic enzymes: bioengineered pancreatic enzymes.

In 2006, Research & Development costs amounted to EUR 424 million (16% of sales)